R

Redhill Biopharma Ltd
D

RDHL

6.80000
USD
-0.32
(-4.49%)
قبل الجلسة
حجم التداول
5
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
8,707,665
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AZN
    AZN
    -0.260
    (-0.40%)
    64.420 USD
    B
    BCRX
    -0.02000
    (-0.27%)
    7.30000 USD
    BNTX
    BNTX
    -1.280
    (-1.15%)
    110.180 USD
    GILD
    GILD
    0.320
    (0.35%)
    90.950 USD
    I
    INO
    0.03500
    (1.97%)
    1.81000 USD
    MRK
    MRK
    -0.160
    (-0.16%)
    98.170 USD
    MRNA
    MRNA
    -0.770
    (-2.01%)
    37.580 USD
    N
    NNVC
    -0.02000
    (-1.33%)
    1.48000 USD
    PFE
    PFE
    0.110
    (0.43%)
    25.990 USD
    REGN
    REGN
    -5.72
    (-0.80%)
    708.78 USD
    V
    VSTM
    -0.04000
    (-0.94%)
    4.22000 USD
    المزيد
الأخبار

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.